| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/21/2004 | CN1146416C Use of H+, K+-ATPase inhibitor in treatment of nasal polyps |
| 04/21/2004 | CN1146415C Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators |
| 04/21/2004 | CN1146414C Amino acid composition and use thereof in immunosuppression |
| 04/21/2004 | CN1146413C Pharmaceutical composition for injection based on paracetamol |
| 04/21/2004 | CN1146412C Use of re-intake inhibitor of noradrenalin in preparatino of medicine against antagonistic |
| 04/21/2004 | CN1146411C Use of 1,3-propanediol derivatives |
| 04/21/2004 | CN1146410C Controlled release formulation |
| 04/21/2004 | CN1146409C Fast decomposing pellets |
| 04/21/2004 | CN1146407C Stable shaped particles of crystalline organic compounds |
| 04/21/2004 | CN1146406C Composition comprising finely divided, crystalling particles of budesnoide |
| 04/21/2004 | CN1146405C Free-flowing dried particles |
| 04/21/2004 | CN1146404C Opthalmic solution comprising glycogen |
| 04/21/2004 | CN1146387C Composition containing L-2-keto thiazolidine-4-carboxylic acid in continuous aqueous phase |
| 04/20/2004 | US6723893 Mice having a mutant SOD-1-encoding transgene |
| 04/20/2004 | US6723858 Breaking cell dividing, reproduction cycles |
| 04/20/2004 | US6723855 Chlorinating 5-methylisoxazole-4-carboxylic acid by reacting with chlorinating agent to form 5-methylisoxazole-4-carboxylic acid chloride, reacting with 4-trifluoromethylaniline in presence of alkali metal or alkaline earth metal bicarbonate |
| 04/20/2004 | US6723854 Preparing intermediates for epithilone a and b, desoxyepothilone a and b, and analogues thereof; haloalkadienyl thiazoles, the aldehyde intermediates; phosphorus halomethylene transfer agent |
| 04/20/2004 | US6723831 Removal antibodies from body fluids |
| 04/20/2004 | US6723755 Method of treating rosacea |
| 04/20/2004 | US6723754 Controlling pain using transferase inhibitor |
| 04/20/2004 | US6723751 Individual polymorphic forms of crystalline sodium salt having specified x-ray diffraction spectra |
| 04/20/2004 | US6723750 Photodynamic therapy for pre-melanomas |
| 04/20/2004 | US6723749 Treating bacterial infections |
| 04/20/2004 | US6723748 Vision disorders; topical applying |
| 04/20/2004 | US6723747 Estrogen receptor modulators useful in treating or inhibiting conditions, disorders, or disease states at least partially mediated by estrogen deficiency or excess, or which may be treated or inhibited through use of estrogenic agent |
| 04/20/2004 | US6723745 Prevention or treatment of autoimmune disease in warm blooded animal |
| 04/20/2004 | US6723744 Indole carboxylic acids as thyroid receptor ligands |
| 04/20/2004 | US6723742 Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators |
| 04/20/2004 | US6723741 Benzimidazoles and benzothiazoles and uses thereof |
| 04/20/2004 | US6723740 Administering therapeutic amount of human peroxisome proliferator activated receptor delta agonist to lower triglycerides |
| 04/20/2004 | US6723739 Glucopyranoside benzothiophenes |
| 04/20/2004 | US6723737 Methods, pharmaceutical and therapeutic compostions for administering adenosine |
| 04/20/2004 | US6723736 For therapy inflammation, inflammatory diseases, immunologic diseases and other diseases mediated by tumor necrosis factor-alpha (tnf-alpha) and/or interleukin 6 or 10 and/or enzyme cyclooxygenase-2 (cox-2) |
| 04/20/2004 | US6723735 Imidazo-pyridine derivatives as ligands for GABA receptors |
| 04/20/2004 | US6723732 Percutaneously adminstrable preparations containing cerebral function activators |
| 04/20/2004 | US6723730 Capsaicin receptor ligands |
| 04/20/2004 | US6723729 Chemical intermediates for anticarcinogenic agent irinotecan |
| 04/20/2004 | US6723728 Polymorphic and other crystalline forms cis-FTC |
| 04/20/2004 | US6723726 Protein tyrosine kinase inhibitors |
| 04/20/2004 | US6723725 Indole derivatives |
| 04/20/2004 | US6723724 Isoxazolylalkylpiperazine derivatives having selective biological activity at dopamine D3 or D4 receptor, and preparation thereof |
| 04/20/2004 | US6723723 Heterocyclic derivatives as inhibitors of factor Xa |
| 04/20/2004 | US6723721 CRF receptor antagonists and methods relating thereto |
| 04/20/2004 | US6723719 Dysmenorrhoea, benign prostatic hyperplasia (bph), bladder outlet obstruction, incontinence, agina, congestive heart failure, atherosclerosis; hypotensive and antiallergen agents |
| 04/20/2004 | US6723718 Substituted α, β-anellated butyrolactones |
| 04/20/2004 | US6723715 14, 15-cyclopropanosteroids of the 19-norandrostane series, method for producing said compounds and pharmaceutical preparation containing said compounds |
| 04/20/2004 | US6723714 Aqueous solvent for corticosteroids |
| 04/20/2004 | US6723713 Use of mometasone furoate for treating upper airway diseases |
| 04/20/2004 | US6723712 For therpay of virus-associated cancer, or non-virus-associated cancer |
| 04/20/2004 | US6723710 Compositions for inhibiting arginase activity |
| 04/20/2004 | US6723706 Modified antisense nucleotides complementary to a section of the human Ha-ras gene |
| 04/20/2004 | US6723704 For cosmetics, drugs, moisturizer |
| 04/20/2004 | US6723703 Administering powder or aerosol to nasal mucosa and osteomeatal complex |
| 04/20/2004 | US6723696 Drug screening for agents to treat hypercalcemia and osteoporosis |
| 04/20/2004 | US6723695 Cytotoxic epstein-barr virus (ebv) t-cell epitopes derived from ebv structural antigens; vaccines |
| 04/20/2004 | US6723552 DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof |
| 04/20/2004 | US6723519 Compositions and method for determining the presence of rat PTTG peptide in a sample |
| 04/20/2004 | US6723372 Spraying grains which consist of a prostane derivative and a cyclodextrin vehicle, forming together a prostane-cyclodextrine-clathrate, with an aqueous polymer dispersion of ethyl cellulose and/or poly(methyl)acrylic acid ester |
| 04/20/2004 | US6723351 Arsenic trioxide and the organic arsenical, melarsoprol, have broad applicability in the treatment of various types of leukemias, lymphomas, and solid tumors |
| 04/20/2004 | US6723348 Orodispersible tablets containing fexofenadine |
| 04/20/2004 | US6723346 Flowable, non-dusty, and binder-free riboflavin granulates can be manufactured from a mixture of riboflavin crystals of modification b and c |
| 04/20/2004 | US6723345 Topical drug preparations |
| 04/20/2004 | US6723343 Pharmaceutical tramadol salts |
| 04/20/2004 | US6723341 Antibiotic product, use and formulation thereof |
| 04/20/2004 | US6723340 Optimal polymer mixtures for gastric retentive tablets |
| 04/20/2004 | US6723338 Liposome- encapsulated vinca alkaloids are unusually effective in the treatment of a variety of forms of lymphoma especially relapsed forms of non-hodgkin's lymphoma |
| 04/20/2004 | US6723337 Non-aqueous acrylic polymer, superior adhesion and durability instead of water-soluble polymer significantly decreases thickness of patch; non-ionic surfactant and terpene are used as absorption enhancers; dissolution assistant is used |
| 04/20/2004 | US6723336 For weight gain or treatment of gastrointestinal disorders in swine and poultry; orally administering a polymer or copolymer of acrolein in an amount up to 5000 mg of polymer or copolymer of acrolein per kilogram of body weight per day |
| 04/20/2004 | US6723328 A homogenized, killed pure microsporum canis culture provided in a carrier wherein the culture is isolated by filtration. |
| 04/20/2004 | US6723326 Topical compositions containing probiotic Bacillus bacteria, spores, and extracellular products and uses thereof |
| 04/20/2004 | US6723321 Modulation of lyase activity; obtain sample containing lyase, incubate with substrate and modulator, monitor adjustment in binding of substrate to lyase, adjustment in binding indicates modulator |
| 04/20/2004 | US6723318 Targeting of biomolecules |
| 04/20/2004 | US6723315 Method for treating amyotrophic lateral sclerosis |
| 04/20/2004 | CA2421976C Medicaments |
| 04/20/2004 | CA2310136C Combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculation disorders |
| 04/20/2004 | CA2300382C New psoralens for pathogen inactivation |
| 04/20/2004 | CA2296336C Analgesic compositions comprising anti-epileptic compounds and methods of using same |
| 04/20/2004 | CA2282461C 2-.beta.-substituted-6-alkylidene penicillanic acid derivatives as .beta.-lactamase inhibitors |
| 04/20/2004 | CA2265746C Agent for inhibition of cytokine production and agent for inhibition of cell adhesion |
| 04/20/2004 | CA2255229C Use of cinnamic acid, or of its derivatives, as a firming agent in a cosmetic composition |
| 04/20/2004 | CA2247405C Slow-release pharmaceutical formulations containing mizolastin |
| 04/20/2004 | CA2246485C Novel derivatives of indole and indazole, process for their preparation and pharmaceutical compositions containing them |
| 04/20/2004 | CA2172265C Transdermal delivery device containing an estrogen |
| 04/20/2004 | CA2140238C Antiviral combinations |
| 04/20/2004 | CA2130678C 2,3,4,5-tetrahydro-1h-3-benzazepines and pharmaceutically acceptable acid addition salts thereof |
| 04/20/2004 | CA2125408C Drug formulations for parenteral use |
| 04/20/2004 | CA2122344C Liposome preparation containing tricyclic compound |
| 04/20/2004 | CA2102778C Novel compositions based on taxane class derivatives |
| 04/20/2004 | CA2087420C Ophthalmic pharmaceutical composition containing n-acetyl-cisteine and polyvinylalcohol |
| 04/20/2004 | CA2054822C Formulations and their use in the treatment of neurological diseases |
| 04/16/2004 | CA2443585A1 New derivatives of (3,4-a:3,4-c) carbazole, their preparation process, and pharmaceutical compositions that contain them |
| 04/16/2004 | CA2408207A1 Peptides binding protein phosphatase 2a and polynucleotides coding them |
| 04/15/2004 | WO2004031777A1 Use of gst-omega-2 as a therapeutic target |
| 04/15/2004 | WO2004031392A1 Mipp1 homologous nucleic acids and proteins involved in the regulation of energy homeostatis |
| 04/15/2004 | WO2004031391A1 Regulation of human pde1a |
| 04/15/2004 | WO2004031374A2 Secondary binding site of dipeptidyl peptidase iv (dp iv) |
| 04/15/2004 | WO2004031294A1 Synergistic uv absorber combination |
| 04/15/2004 | WO2004031233A2 Novel chemokine-like polypeptides |
| 04/15/2004 | WO2004031210A2 Optimized multi-epitope constructs and uses thereof |
| 04/15/2004 | WO2004031203A1 Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same |